Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Non Small Cell Lung Cancer Metastatic × lorlatinib × Clear all

Phase

Status

Recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 5 Non Small Cell Lung Cancer Metastatic 1 Meningeal Carcinomatosis 1 Lung Neoplasms 1 Brain Neoplasms 1 Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer 1

Interventions

pembrolizumab 1 lorlatinib 1 atezolizumab 1 Paclitaxel 1 Fecal Microbiota Transplantation 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04621188 2025-09-24

Lorlatinib After Failure of First-line TKI in Patients With Advanced ROS1-positive NSCLC (ALBATROS)

Intergroupe Francophone de Cancerologie Thoracique

Phase 2 Active not recruiting

Non Small Cell Lung Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡